J&J said that serious adverse events , such as accidents or illnesses, are"an expected part of any clinical study, especially large studies."
J&J's announcement was followed Tuesday afternoon by news that Eli Lilly had also paused a trial of a coronavirus antibody treatment out of safety concerns.The companies' announcements were also a drag on the broader market, said Briefing.com analyst Patrick O'Hare. Travel-related stocks, which are seen as major beneficiaries of a coronavirus vaccine, suffered especially big drops.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States United States Latest News, United States United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
'Blue wave' US election expectations trigger green stocks frenzyGrowing expectations of a strong Democratic victory in U.S. elections have prompted investors to snap up renewable energy stocks, amplifying a ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Nasdaq jumps 2.6 per cent as tech leads US stocks to close higherNEW YORK (AFP) - Tech shares led US stocks higher Monday, with Apple surging ahead of a new iPhone launch as investors shrugged off the stalemate over US stimulus talks in Washington.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »
Tokyo: Stocks close higher after US rallies[TOKYO] Tokyo stocks closed marginally higher in sluggish trading on Tuesday following rallies on Wall Street, as investors remained on the sidelines ahead of Japan's corporate results season. Read more at The Business Times.
Source: BusinessTimes - 🏆 15. / 51 Read more »